128 related articles for article (PubMed ID: 2842525)
1. Effects of repeated exposure to cyclophosphamide on drug resistance and biological properties of a newly autonomy-acquired mouse mammary tumor (T4-OI320).
Takeda Y; Matsuzawa A; Kaneko T; Sekiguchi M; Fujii G
Jpn J Exp Med; 1988 Apr; 58(2):87-98. PubMed ID: 2842525
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic estrogen receptor in a pregnancy-dependent mouse mammary tumor (TPDMT-4) and related autonomous lines.
Matsuzawa A; Mizuno Y; Yamamoto T; Hori T; Suzuki T
Cancer Res; 1980 Sep; 40(9):3361-8. PubMed ID: 7427949
[TBL] [Abstract][Full Text] [Related]
3. Clonal variations among multiple primary mammary tumors and within a tumor of individual mice: insertion mutations of int oncogenes.
Sarkar NH
Virology; 1995 Oct; 212(2):490-9. PubMed ID: 7571419
[TBL] [Abstract][Full Text] [Related]
4. Accelerated progression to autonomy of a pregnancy-dependent mouse mammary tumor (TPDMT-4) by hormones.
Matsuzawa A; Kaneko T; Ikeda Y
Cancer Res; 1983 May; 43(5):2283-9. PubMed ID: 6831452
[TBL] [Abstract][Full Text] [Related]
5. Progression of pregnancy-dependent mouse mammary tumors after long dormancy periods. Involvement of Wnt pathway activation.
Gattelli A; Cirio MC; Quaglino A; Schere-Levy C; Martinez N; Binaghi M; Meiss RP; Castilla LH; Kordon EC
Cancer Res; 2004 Aug; 64(15):5193-9. PubMed ID: 15289324
[TBL] [Abstract][Full Text] [Related]
6. Genistein alone or combined with cyclophosphamide may stimulate 16/C transplantable mouse mammary cancer growth.
Wietrzyk J; Mazurkiewicz M; Madej J; Dzimira S; Grynkiewicz G; Radzikowski C; Opolski A
Med Sci Monit; 2004 Nov; 10(11):BR414-9. PubMed ID: 15507846
[TBL] [Abstract][Full Text] [Related]
7. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.
Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA
Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624
[TBL] [Abstract][Full Text] [Related]
8. Comparative studies on estrogen receptors between a pregnancy-dependent mouse mammary tumor (TPDMT-4) and related autonomous tumors.
Matsuzawa A; Hayakawa T; Takitani S; Iwaguchi T
Endocrinology; 1987 Jun; 120(6):2346-56. PubMed ID: 3569134
[TBL] [Abstract][Full Text] [Related]
9. Establishment and characterization of immortalized non-transplantable mouse mammary cell lines cloned from a MMTV-induced tumor cell line cultured for a long duration.
Takenaka T; Saga S; Miyaishi O; Imai M; Yokoi T; Lu J; Wajjwalku W; Kusakabe M; Taguchi O; Matsuyama M
Nagoya J Med Sci; 1991 Mar; 53(1-4):9-21. PubMed ID: 1666666
[TBL] [Abstract][Full Text] [Related]
10. Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas.
Theodorou V; Boer M; Weigelt B; Jonkers J; van der Valk M; Hilkens J
Oncogene; 2004 Aug; 23(36):6047-55. PubMed ID: 15208658
[TBL] [Abstract][Full Text] [Related]
11. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of C3H/He mouse mammary tumor growth by combined treatment with cyclophosphamide and polyadenylic-polyuridylic acid.
Youn JK; Lacour F; Hue G
Cancer Res; 1982 Nov; 42(11):4706-11. PubMed ID: 7127305
[TBL] [Abstract][Full Text] [Related]
13. Differential response of an ovarian-responsive mouse mammary tumor to androgenic and estrogenic agents.
Matsuzawa A; Ikeda Y
Cancer Res; 1983 Aug; 43(8):3680-6. PubMed ID: 6861137
[TBL] [Abstract][Full Text] [Related]
14. The antitumor effect of postoperative treatment with genistein alone or combined with cyclophosphamide in mice bearing transplantable tumors.
Wietrzyk J; Opolski A; Madej J; Radzikowski C
Acta Pol Pharm; 2000 Nov; 57 Suppl():5-8. PubMed ID: 11293263
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of p21(WAF1/CIP1) deficiency on MMTV-ras and MMTV-myc mammary tumor properties.
Bearss DJ; Lee RJ; Troyer DA; Pestell RG; Windle JJ
Cancer Res; 2002 Apr; 62(7):2077-84. PubMed ID: 11929828
[TBL] [Abstract][Full Text] [Related]
16. Association of hst gene expression with metastatic phenotype in mouse mammary tumors.
Murakami A; Tanaka H; Matsuzawa A
Cell Growth Differ; 1990 May; 1(5):225-31. PubMed ID: 1964796
[TBL] [Abstract][Full Text] [Related]
17. Effects of treatment with cyclophosphamide on hormone-dependent and hormone-independent tumor cells in transplanted GR mouse mammary tumors.
Sluyser M; Benckhuysen C
Cancer Treat Rep; 1977 Aug; 61(5):861-7. PubMed ID: 890694
[TBL] [Abstract][Full Text] [Related]
18. Insertional mutation of int protooncogenes in the mammary tumors of a new strain of mice derived from the wild in China: normal- and tumor-tissue-specific expression of int-3 transcripts.
Sarkar NH; Haga S; Lehner AF; Zhao W; Imai S; Moriwaki K
Virology; 1994 Aug; 203(1):52-62. PubMed ID: 8030284
[TBL] [Abstract][Full Text] [Related]
19. Effects of combination estrogen:cyclophosphamide treatment on the growth of the MXT transplantable mammary tumor in the mouse.
Markaverich BM; Medina D; Clark JH
Cancer Res; 1983 Jul; 43(7):3208-11. PubMed ID: 6850631
[TBL] [Abstract][Full Text] [Related]
20. Preferential activation of Fgf8 by proviral insertion in mammary tumors of Wnt1 transgenic mice.
Kapoun AM; Shackleford GM
Oncogene; 1997 Jun; 14(24):2985-9. PubMed ID: 9205106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
